Vitamin C metabolomic mapping in experimental diabetes with 6-deoxy-6-fluoro-ascorbic acid and high resolution 19F-nuclear magnetic resonance spectroscopy

Metabolism: Clinical and Experimental

Volumn 52, Issue 6, 2003, Pages 760-770

  Nishikawa, Yoko ^a,b,c   Dmochowska, Barbara ^a,b,c   Madaj, Janusz ^a,b,c   Xue, Jie ^a,b,c   Guo, Zhongwu ^a,b,c   Satake, Makoto ^a,b,c   Reddy, D Venkat ^a,b,c   Rinaldi, Peter L ^a,b,c   Monnier, Vincent M ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GDA SK   (Poland)

^c UNIVERSITY OF AKRON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIOXOGULONIC ACID; 6 DEOXY 6 FLUOROASCORBIC ACID; ASCORBIC ACID; COPPER ION; FLUORINE; FLUORODEHYDROASCORBIC ACID; GLUCOSE; UNCLASSIFIED DRUG; 6-DEOXY-6-FLUOROASCORBIC ACID; DEHYDROASCORBIC ACID; DRUG DERIVATIVE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASCORBIC ACID METABOLISM; BODY WEIGHT; BRAIN; CATABOLISM; CONTROLLED STUDY; DEGRADATION; EXPERIMENTAL DIABETES MELLITUS; HEART; HOMEOSTASIS; IN VITRO STUDY; KIDNEY; KIDNEY FUNCTION; LIVER; MALE; METABOLIC PARAMETERS; METABOLITE; METABOLOMIC MAPPING; METAL METABOLISM; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; PLASMA; PRIORITY JOURNAL; RAT; SPLEEN; TISSUE LEVEL; TISSUE SPECIFICITY; URINALYSIS; ANIMAL; BLOOD; KINETICS; METABOLISM; ORGAN SIZE; OSMOLARITY; OXIDATION REDUCTION REACTION; SPRAGUE DAWLEY RAT; SYNTHESIS; URINE;

2,3-DIKETOGULONIC ACID; ANIMALS; ASCORBIC ACID; BODY WEIGHT; DEHYDROASCORBIC ACID; DIABETES MELLITUS, EXPERIMENTAL; FLUORINE; FLUORINE RADIOISOTOPES; HOMEOSTASIS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; ORGAN SIZE; OSMOLAR CONCENTRATION; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0038142243     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00069-6     Document Type: Article

References (63)

1. Watkins SM, German JB: Toward the implementation of metabolomic assessments of human health and nutrition. Curr Opin Biotechnol 13:512-516, 2002
2. Fiehn O: Metabolomics - The link between genotypes and phenotypes. Plant Mol Biol 48:155-71, 2002
3. Reo NV: NMR-based metabolomics. Drug Chem Toxicol 25:375-378, 2002
4. Niki E, Saito T, Kamiya Y: The role of vitamin C as an antioxidant. Chem Lett 631-632, 1983
5. Dandona P, Thusu K, Cook S, et al: Oxidative damage to DNA in diabetes mellitus. Lancet 347:444-445, 1996
6. Low PA, Nickander KK, Tritschler HJ: The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46:S38-42, 1997 (suppl 2)
7. Will JC, Byers T: Does diabetes mellitus increase the requirement for vitamin C? Nutr Rev 54:193-202, 1996
8. Sinclair AJ, Girling AJ, Gray L, et al: Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia 34:171-175, 1991
9. Levine M, Cantilena CC, Dhariwal KR: In situ kinetics and ascorbic acid requirements. World Rev Nutr Diet 72:114-127, 1993
10. Young IS, Torney JJ, Trimble ER: The effect of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 13:41-46, 1992
11. Levine M, Daruwala RC, Park JB, et al: Does vitamin C have a pro-oxidant effect? Nature 395:231, 1998 (discussion 232)
12. Koshiishi I, Mamura Y, Liu J, et al: Degradation of dehydroascorbate to 2,3-diketogulonate in blood circulation. Biochim Biophys Acta 1425:209-214, 1998
13. Bode AM, Cunningham L, Rose RC: Spontaneous decay of oxidized ascorbic acid (dehydro-L-ascorbic acid) evaluated by high-pressure liquid chromatography. Clin Chem 36:1807-1809, 1990
14. Shin DB, Feather MS: 3-Deoxy-L-glycero-pentos-2-ulose (3-deoxy-L-xylosone) and L-threo-pentos-2-ulose (L-xylosone) as intermediates in the degradation of L-ascorbic acid. Carbohydr Res 208:246-250, 1990
15. Simpson GL, Ortwerth BJ: The non-oxidative degradation of ascorbic acid at physiological conditions. Biochim Biophys Acta 1501:12-24, 2000
16. Dunn JA, Ahmed MU, Murtiashaw MH, et al: Reaction of ascorbate with lysine and protein under autoxidizing conditions: Formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate. Biochemistry 29:10964-10970, 1990
17. Ortwerth BJ, James H, Simpson G, et al: The generation of superoxide anions in glycation reactions with sugars, osones, and 3-deoxyosones. Biochem Biophys Rec Commun 245:161-165, 1998
18. Nagaraj RH, Monnier VM: Isolation and characterization of a blue fluorophore from human eye lens crystallins: In vitro formation from Maillard reaction with ascorbate and ribose. Biochim Biophys Acta 1116:34-42, 1992
19. Nagaraj RH, Sell DR, Prabhakaram M, et al: High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc Natl Acad Sci USA 88:10257-10261, 1991
20. Ahmed MU, Thorpe SR, Baynes JW: Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261:4889-4894, 1986
21. Tessier F, Obrenovich M, Monnier VM: Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis. J Biol Chem 274:20796-20804, 1999
22. Nagaraj RH, Shamsi FA, Huber B, et al: Immunochemical detection of oxalate monoalkylamide, an ascorbate-derived Maillard reaction product in the human lens. FEBS Lett 453:327-330, 1999
23. Organisciak DT, Wang HM, Kou AL: Ascorbate and glutathione levels in the developing normal and dystrophic rat retina: Effect of intense light exposure. Curr Eye Res 3:257-267, 1984
24. Tso MO, Woodford BJ, Lam KW: Distribution of ascorbate in normal primate retina and after photic injury: A biochemical, morphological correlated study. Curr Eye Res 3:181-191, 1984
25. Weiss MF, Erhard P, Kader-Attia FA, et al: Mechanisms for the formation of glycoxidation in end-stage renal disease. Kidney Int 57:2571-2585, 2000
26. 13C-NMR studies of transmembrane electron transfer to extracellular ferricyanide in human erythrocytes. Eur J Biochem 246:638-645, 1997
27. Madaj J, Nishikawa Y, Reddy VP, et al: 6-Deoxy-6-fluoro-L-ascorbic acid: Crystal structure and oxidative degradation. Carbohydr Res 329:477-485, 2000
28. Kagawa Y: Enzymatic studies on ascorbic acid catabolism in animal: T catabolism of 2,3-diketo-L-gulonic acid. J Biochem 51:134-144, 1962
29. Otsuka M, Kurata T, Arakawa N: Isolation and characterization of an intermediate product in the degradation of 2,3-diketo-L-gulonic acid. Agric Biol Chem 50:531-533, 1986
30. Sapper H, Kang SO, Paul HH, et al: The reversibility of the vitamin C redox system: Electrochemical reasons and biological aspects. Z Naturforsch [C] 37:942-946, 1982
31. Yue DK, McLennan S, Fisher E, et al: Ascorbic acid metabolism and polyol pathway in diabetes. Diabetes 38:257-261, 1989
32. 14C) dehydroascorbic acid in male guinea pigs after intravenous injection. Int J Vitam Nutr Res 42:223-241, 1972
33. Rumsey SC, Welch RW, Garraffo HM, et al: Specificity of ascorbate analogs for ascorbate transport. Synthesis and detection of [(125)I] 6-deoxy-6-iodo-L-ascorbic acid and characterization of its ascorbate-specific transport properties. J Biol Chem 274:23215-23222, 1999
34. 19F-NMR spectroscopy. Invest Ophthalmol Vis Sci (in press)
35. Kashiba M, Oka J, Ichikawa R, et al: Impaired reductive regeneration of ascorbic acid in the Goto-Kakizaki diabetic rat. Biochem J 351:313-318, 2000
36. Lindsay RM, Jamieson NS, Walker SA, et al: Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes. Diabetologia 41:516-523, 1998
37. Wayner DD, Burton GW, Ingold KU, et al: The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 924:408-419, 1987
38. Asayama K, Uchida N, Nakane T, et al: Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Radic Biol Med 15:597-602, 1993
39. Saxena P, Saxena AK, Cui XL, et al: Transition meta-catalyzed oxidation of ascorbate in human cataract extracts: Possible role of advanced glycation end products. Invest Ophthalmol Vis Sci 41:1473-481, 2000
40. Requena JR, Groth D, Legname G, et al: Copper-catalyzed oxidation of the recombinant SHa(29-231) prion protein. Proc Natl Acad Sci USA 98:7170-7175, 2001
41. Qian M, Liu M, Eaton JW: Transition metals bind to glycated proteins forming redox active "glycochelates": Implications for the pathogenesis of certain diabetic complications. Biochem Biophys Res Commun 250:385-389, 1998
42. Lee C, Yim MB, Chock PB, et al: Oxidation-reduction properties of methylgloxal-modified protein in relation to free radical generation. J Biol Chem 273:25272-25278, 1998
43. Nishikawa T, Edelstein D, Du XL, et al: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
44. Squadrito GL, Jin X, Pryor WA: Stopped-flow kinetic study of the reaction of ascorbic acid with peroxynitrite. Arch Biochem Biophys 322:53-59, 1995
45. Smith C, Mitchinson MJ, Aruoma OI, et al: Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J 286:901-905, 1992
46. Monnier VM: Transition metals redox: Reviving an old plot for diabetic vascular disease. J Clin Invest 107:799-801, 2001
47. Saxena AK, Saxena P,Wu X, et al: Protein aging by carboxy-methylation of lysines generates sites for divalent metal and redox active copper binding: Relevance to diseases of glycoxidative stress. Biochem Biophys Res Commun 260:332-338, 1999
48. Wells-Knecht MC, Lyons TJ, McCance DR, et al: Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes. J Clin Invest 100:839-846, 1997
49. Mitton KP, Dzialoszynski T, Sanford SE, et al: Cysteine and ascorbate loss in the diabetic rat lens prior to hydration changes. Curr Eye Res 16:564-571, 1997
50. Slonin AE, Fletcher T, Burke V, et al: Effect of streptozotocin on red-blood-cell-reduced glutatione: Modification by glucose, nicotinamide, and epinephrine. Diabetes 25:216-222, 1976
51. Obrosova IG, Van Huysen C, Fathallah L, et al: An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J 16:123-125, 2002
52. De Cavanagh EM, Inserra F, Ferder L, et al: Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues. Am J Physiol 278:R572-577, 2000
53. Rauscher FM, Sanders RA, Watkins JB III: Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 15:159-164, 2001
54. Seib PA, Tolbert BM: Ascorbic Acid: Chemistry, Metabolism, and Uses. Washington, DC, American Chemical Society, 1982, pp 293-316
55. Tsukaguchi H, Tokui T, Mackenzie B, et al: A family of mammalian Na+-dependent L-ascorbic acid transportes. Nature 399:70-75, 1999
56. Ngkeekwong FC, Ng LL: Two distinct uptake mechanisms for ascorbate and dehydroascorbate in human lymphoblasts and their interaction with glucose. Biochem J 324:225-230, 1997
57. Slater AF, Nobel CS, Orrenius S: The role of intracellular oxidants in apoptosis. Biochim Biophys Acta 1271:59-62, 1995
58. Takao T, Tojo C, Nishioka T, et al: Increased adrenocorticotropin responses to acute stress in Otsuka Long-Evans Tokushima Fatty (type 2 diabetic) rats. Brain Res 852:110-115, 2000
59. Hirano T, Horigome H, Ishishita H, et al: Oxidized glucocorticoids counteract glucocorticoid-induced apoptosis in murine thymocytes in vitro. Life Sci 68:2905-2916, 2001
60. Tolbert BM, Downing M, Carlson RW, et al: Chemistry and metabolism of ascorbic acid and ascorbate sulfate. Ann N Y Acad Sci 258:48-69, 1975
61. Baker EM, Saari JC, Tolbert BM: Ascorbic acid metabolism in man. Am J Clin Nutr 19:371-378, 1966
62. Tolbert BM, Harkrader RJ, Johnson DO, et al: C-6 oxidation of ascorbic acid: A major metabolic process in animals. Biochem Biophys Res Commun 71:1004-1009, 1976
63. Bultitude FW, Newham SJ: Identification of some abnormal metabolites in plasma from uremic subjects. Clin Chem 21:1329-1334, 1975